Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,471 public trials 501 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

NCT07028489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • Torrance Memorial Physician Network-Cancer Care Torrance, California, United States
  • John Muir Health Walnut Creek, California, United States
  • Bayhealth Cancer Center- Kent Dover, Delaware, United States
View Trial Details
Recruiting

SLV-154 Treatment of Advanced Cancers

NCT06771219

Conditions
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer, +5 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Washington University St Louis, Missouri, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
  • TRIO-US (Translational Research in Oncology-US) Los Angeles, California, United States
View all 284 locations
View Trial Details
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View all 35 locations
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 56 locations
View Trial Details
Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

NCT07213804

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Phoenix, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center Burbank, California, United States
  • City of Hope, Duarte Duarte, California, United States
View all 267 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

NCT05803382

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +17 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • Memorial Hospital East Shiloh, Illinois, United States
View all 22 locations
View Trial Details
Recruiting

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

NCT07403721

Conditions
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR), Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Midwestern Regional Medical Center dba City of Hope Chicago Zion, Illinois, United States
  • Community Health Network MD Anderson Cancer Center - North Indianapolis, Indiana, United States
  • New England Cancer Specialists Westbrook, Maine, United States
View all 25 locations
View Trial Details

Related conditions